Last Thursday, the Centers for Medicare and Medicaid Services (CMS) announced that it would reverse course on anti-amyloid treatments for Alzheimer's patients and cover Leqembi should it receive full approval from the U.S. Food and Drug Administration (FDA). June is Alzheimer's Awareness month.
Leqembi, produced by Biogen and Eisai,...
Over 6 million Americans, including 150,000 Arizonans are currently living with Alzheimer's Disease. As the need for treatment grows, groups like the Alzheimer's Association are asking the government to strengthen its commitment to research and accessibility. But a Congressional report suggests the U.S. Food and Drug Administration (FDA)...
The Centers for Medicare and Medicaid Services (CMS) proposed Tuesday to cover the controversial drug Aduhelm when used as an Alzheimer’s treatment in clinical trials. While debate about the drug’s safety has been intense, CMS believes continued clinical trials will address unanswered questions related to the drug’s adverse side...Arizona News
Of the 5.7 million Americans living with Alzheimer's dementia, 140,000 are Arizona residents. By 2025, that number is expected to increase by 42.9 percent, up to 200,000 people in Arizona.
The cost of caring for people with Alzheimer's or other dementias will surpass $277 billion nationwide, according to a new report released by the...
